Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12759079 | 0.78 | EPHX2 (0.38) | ALDH1A1HSD17B10TSHRHTTMAPK1 | |
| SCHEMBL12759095 | 0.77 | SIGMAR1 (0.42) | — | |
| SCHEMBL6266176 | 0.71 | ALDH1A1 (0.58) | ALDH1A1MEN1KMT2ATSHRKDM4E | |
| SCHEMBL3008249 | 0.70 | ALDH1A1 (0.49) | ALDH1A1TP53HSD17B10MEN1KMT2A | |
| SCHEMBL12453115 | 0.70 | DAO (0.43) | ALDH1A1MEN1KMT2AHTTLMNA | |
| SCHEMBL656154 | 0.69 | KMT2A (0.44) | ALDH1A1MEN1KMT2ATSHRHTT | |
| SCHEMBL29285318 | 0.69 | TAAR1 (0.57) | — | |
| SCHEMBL19457401 | 0.69 | LMNA (0.43) | ALDH1A1MEN1KMT2ATSHRLMNA | |
| SCHEMBL775989 | 0.69 | LMNA (0.43) | ALDH1A1MEN1KMT2ATSHRLMNA | |
| SCHEMBL7735405 | 0.68 | DAO (0.41) | ALDH1A1MEN1KMT2ATSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8466306-B2 | Sulfonated organophosphine compounds and use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-8466306-B2 | Sulfonated organophosphine compounds and use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | ORMDL3, IP6K3, ALK | ALDH1A1 573/4885TP53 3958/4885HSD17B10 1745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.